日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Exploratory analyses of clinical outcomes from the BIIB080 phase 1b study in mild Alzheimer's disease

对BIIB080 1b期研究中轻度阿尔茨海默病患者的临床结果进行探索性分析

期刊:Nature Aging
影响因子:19.4
doi:10.1038/s43587-025-01031-9
Shulman, Melanie; Wu, Shuang; Ziogas, Nick; Edwards, Amanda; Collins, Jessica; Lin, Lin; Tien, Irene; Curiale, Gioacchino; Li, Yumeng; Mummery, Catherine; Lane, Roger; Junge, Candice; Beaver, John; Tian, Ying; Landen, Jaren; Bullain, Szofia; Gallagher, Diana
阿尔茨海默症
发表日期：2026
文献求助 收藏

Erratum to "Results of the first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study of BIIB113 in healthy volunteers" [The Journal of Prevention of Alzheimer's Disease volume 12 (2025) 100302]

对“BIIB113 在健康志愿者中首次人体随机、双盲、安慰剂对照、单次和多次递增剂量研究的结果”的勘误 [阿尔茨海默病预防杂志第 12 卷（2025 年）100302]

期刊:Jpad-Journal of Prevention of Alzheimers Disease
影响因子:7.8
doi:10.1016/j.tjpad.2025.100425
Nery, Flavia C; Kaliszczak, Maciej; Suttle, Ben; Jones, Lori; Wu, Shuang; Xie, Jing; Curiale, Gioacchino; Yesilalan, Esin; Hirschhorn, Beth; Wilkes, Denisa; Singh, Dave; Bolin, Martin; Nag, Sangram; Varrone, Andrea; Stenkrona, Per; Morén, Anton Forsberg; Halldin, Christer; Yachnin, Jeffrey; Arnold, H Moore; Bullain, Szofia; Landen, Jaren; Gallagher, Diana; Hering, Heike
阿尔茨海默症
发表日期：2026
文献求助 收藏

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease

早期阿尔茨海默病甘特鲁单抗临床试验中的淀粉样蛋白相关影像异常（ARIA）

期刊:Jama Neurology
影响因子:21.3
doi:10.1001/jamaneurol.2024.3937
Salloway, Stephen; Wojtowicz, Jakub; Voyle, Nicola; Lane, Christopher A; Klein, Gregory; Lyons, Marco; Rossomanno, Simona; Mazzo, Francesca; Bullain, Szofia; Barkhof, Frederik; Bittner, Tobias; Schneider, Andres; Grundman, Michael; Aldea, Roxana; Boada, Mercè; Smith, Janice; Doody, Rachelle
阿尔茨海默症
发表日期：2025
文献求助 收藏

Results of the first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study of BIIB113 in healthy volunteers

首次在健康志愿者中进行的 BIIB113 人体随机、双盲、安慰剂对照、单次和多次递增剂量研究结果

期刊:Jpad-Journal of Prevention of Alzheimers Disease
影响因子:7.8
doi:10.1016/j.tjpad.2025.100302
Nery, Flavia C; Kaliszczak, Maciej; Suttle, Ben; Jones, Lori; Wu, Shuang; Xie, Jing; Curiale, Gioacchino; Yesilalan, Esin; Hirschhorn, Beth; Wilkes, Denisa; Singh, Dave; Bolin, Martin; Nag, Sangram; Varrone, Andrea; Stenkrona, Per; Morén, Anton Forsberg; Halldin, Christer; Yachnin, Jeffrey; Arnold, H Moore; Bullain, Szofia; Landen, Jaren; Gallagher, Diana; Hering, Heike
发表日期：2025
文献求助 收藏

Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD)

Gantenerumab 在阿尔茨海默病患者中的长期安全性：一项 III 期、双盲、开放标签扩展研究（Marguerite RoAD）

期刊:Journal of Alzheimers Disease
影响因子:3.1
doi:10.3233/JAD-240221
Neve, Anuja; Das, Bibha; Wojtowicz, Jakub; Huang, Zhiyue; Bullain, Szofia; Watkin, Michelle; Lott, Dominik; Bittner, Tobias; Delmar, Paul; Klein, Gregory; Hofmann, Carsten; Kerchner, Geoffrey A; Smith, Janice; Baudler, Monika; Fontoura, Paulo; Doody, Rachelle S
阿尔茨海默症
发表日期：2024
文献求助 收藏

Validation of 3- and 5-point severity scales to assess ARIA-E

验证3分制和5分制严重程度量表在评估ARIA-E中的应用

期刊:Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
影响因子:4.4
doi:10.1002/dad2.12503
Bracoud, Luc; Klein, Gregory; Lyons, Marco; Scelsi, Marzia A; Wojtowicz, Jakub; Bullain, Szofia; Purcell, Derk; Fiebach, Jochen B; Barakos, Jerome; Suhy, Joyce
发表日期：2023
文献求助 收藏

In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic model

利用半机制模型对gantenerumab开放标签扩展试验中淀粉样蛋白相关影像异常进行计算机模拟探索

期刊:Alzheimer's and Dementia: Translational Research and Clinical Interventions
影响因子:6.8
doi:10.1002/trc2.12306
Aldea, Roxana; Grimm, Hans Peter; Gieschke, Ronald; Hofmann, Carsten; Lott, Dominik; Bullain, Szofia; Delmar, Paul; Klein, Gregory; Lyons, Marco; Piazza, Fabrizio; Carare, Roxana O; Mazer, Norman A
发表日期：2022
文献求助 收藏

Comparing ARIA-E severity scales and effects of treatment management thresholds

比较ARIA-E严重程度分级和治疗管理阈值的影响

期刊:Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
影响因子:4.4
doi:10.1002/dad2.12376
Klein, Gregory; Scelsi, Marzia A; Barakos, Jerome; Fiebach, Jochen B; Bracoud, Luc; Suhy, Joyce; Delmar, Paul; Lyons, Marco; Wojtowicz, Jakub; Bullain, Szofia; Barkhof, Frederik; Purcell, Derk
发表日期：2022
文献求助 收藏

Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma

开发第三代抗 EGFRvIII 嵌合 T 细胞和表达 EGFRvIII 的人工抗原呈递细胞用于胶质瘤的过继细胞治疗

期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0199414
Ayguen Sahin, Carlos Sanchez, Szofia Bullain, Peter Waterman, Ralph Weissleder, Bob S Carter
神经
肿瘤
胶质瘤
T细胞
发表日期：2018
文献求助 收藏

Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study

高血压发病年龄与高龄老人痴呆风险：90岁以上人群研究

期刊:Alzheimers & Dementia
影响因子:11.1
doi:10.1016/j.jalz.2016.09.007
Corrada, María M; Hayden, Kathleen M; Paganini-Hill, Annlia; Bullain, Szofia S; DeMoss, Jaime; Aguirre, Colette; Brookmeyer, Ron; Kawas, Claudia H
心血管
高血压
发表日期：2017
文献求助 收藏